Form D · Pharmaceuticals
ROCK CREEK PHARMACEUTICALS, INC.
Sarasota, FL · CIK 0000776008
Offering snapshot reported Apr 13, 2016 · SEC filing
- Reported sold
- $500K Offering amount: $500K
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 30, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 13, 2016 | Initial | $500,000 | No comparison | 7 | SEC filing |
| Oct 21, 2015 | Initial | $20,000,000 | No comparison | 2 | SEC filing |
| May 19, 2015 | Initial | $232,770 | No comparison | 1 | SEC filing |
| Feb 12, 2015 | Initial | $760,023 | No comparison | 7 | SEC filing |
| Aug 22, 2014 | Initial | $6,000,000 | No comparison | 5 | SEC filing |
| Mar 15, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-261206
Source: Form D, filed Apr 13, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lee M. Canaan | Director |
| Christopher C. Chapman | Director, Executive |
| Benjamin M. Dent | Executive |
| Park A. Dodd, Iii | Executive |
| Edward J. Mc Donnell | Director |
| William L. Mc Mahon | Executive |
| Michael J. Mullan | Director, Executive |
| Sunitha Chundru Samuel | Director |
| Robert W Scannell | Director |
| Scott P. Sensenbrenner | Director |
| Thomas L. Wilson | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2040 Whitfield Avenue Suite 300
Sarasota, FL, 34243
Sarasota, FL, 34243